Sputum Cytokine Profiling in COPD: Comparison Between Stable Disease and Exacerbation

References

• Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27.
   PubMed Web of Science ®Google Scholar
• Brightling C, Greening N. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 2019;54:1900651.
   PubMed Web of Science ®Google Scholar
• Caramori G, Casolari P, Barczyk A, Durham AL, Di Stefano A, Adcock I. COPD immunopathology. Semin Immunopathol. 2016;38:497–515.
   PubMed Web of Science ®Google Scholar
• Brandsma CA, Van den Berge M, Hackett TL, Brusselle G, Timens W. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine. J Pathol. 2020;250:624–635.
   PubMed Web of Science ®Google Scholar
• Higham A, Quinn AM, Cançado JED, Singh D. The pathology of small airways disease in COPD: historical aspects and future directions. Respir Res. 2019;20:49.
   PubMed Web of Science ®Google Scholar
• Pavord ID. Biologics and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2018;141:1983–1991.
   PubMed Web of Science ®Google Scholar
• Brightling CE. Chronic obstructive pulmonary disease phenotypes, biomarkers, and prognostic indicators. Allergy Asthma Proc. 2016;37:432–438.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Inflammatory endotypes in COPD. Allergy. 2019;74:1249–1256.
   PubMed Web of Science ®Google Scholar
• Hultschig C, Kreutzberger J, Seitz H, Konthur Z, Büssow K, Lehrach H. Recent advances of protein microarrays. Curr Opin Chem Biol. 2006;10:4–10.
   PubMed Web of Science ®Google Scholar
• Dragonieri S, Tongoussouva O, Zanini A, Imperatori A, Spanevello A. Markers of airway inflammation in pulmonary diseases assessed by induced sputum. Monaldi Arch Chest Dis. 2009;71:119–126.
   PubMedGoogle Scholar
• Gray RD, MacGregor G, Noble D, et al. Sputum proteomics in inflammatory and suppurative respiratory diseases. Am J Respir Crit Care Med. 2008;178:444–452.
   PubMed Web of Science ®Google Scholar
• Eickmeier O, Huebner M, Herrmann E, et al. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function. Cytokine. 2010;50:152–157.
   PubMed Web of Science ®Google Scholar
• Hastie AT, Moore WC, Meyers DA, et al. National Heart, Lung, and Blood Institute Severe Asthma Research Program. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol. 2010;125:1028–1036.
   PubMed Web of Science ®Google Scholar
• Singh D, Fox SM, Tal-Singer R, Bates S, Riley JH, Celli B. Altered gene expression in blood and sputum in COPD frequent exacerbators in the ECLIPSE cohort. PLoS One. 2014;9:e107381.
   PubMed Web of Science ®Google Scholar
• Singh D, Fox SM, Tal-Singer R, et al. ECLIPSE Investigators. Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers. Thorax. 2011;66:489–495.
   PubMed Web of Science ®Google Scholar
• Peters MC, Mekonnen ZK, Yuan S, Bhakta NR, Woodruff PG, Fahy JV. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol. 2014;133:388–394.
   PubMed Web of Science ®Google Scholar
• Mamessier E, Boniface S, Dupuy P, Reynaud-Gaubert M, Vervloet D, Magnan A. Study of cytokine gene expression in small cell samples: use in induced sputum. J Immunol Methods. 2003;280:37–47.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555.
   PubMed Web of Science ®Google Scholar
• Drozdovszky O, Barta I, Antus B. Sputum eicosanoid profiling in exacerbations of chronic obstructive pulmonary disease. Respiration. 2014;87:408–415.
   PubMed Web of Science ®Google Scholar
• Paska C, Barta I, Drozdovszky O, Antus B. Elimination of bacterial DNA during RNA isolation from sputum: bashing bead vortexing is preferable over prolonged DNase treatment. PLoS One. 2019;14:e0214609.
   PubMed Web of Science ®Google Scholar
• Antus B, Barta I, Czebe K, Horvath I, Csiszer E. Analysis of cytokine pattern in exhaled breath condensate of lung transplant recipients with bronchiolitis obliterans syndrome. Inflamm Res. 2010;59:83–86.
   PubMed Web of Science ®Google Scholar
• Barta I, Kullmann T, Csiszer E, Antus B. Analysis of cytokine pattern in exhaled breath condensate of patients with squamous cell lung carcinoma. Int J Biol Markers. 2010;25:52–56.
   PubMed Web of Science ®Google Scholar
• Páska C, Bögi K, Szilák L, et al. Effect of formalin, acetone, and RNAlater fixatives on tissue preservation and different size amplicons by real-time PCR from paraffin-embedded tissue. Diagn Mol Pathol. 2004;13:234–240.
   PubMedGoogle Scholar
• Paska C, Barta I, Drozdovszky O, Antus B. Improving gene-expression studies from sputum: a multistep optimization of RNA isolation and qPCR protocols. Am J Respir Cell Mol Biol. 2017;57:626–628.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lin P, Hong C, et al. Serum cytokine profiles in patients with chronic obstructive pulmonary disease associated pulmonary hypertension identified using protein array. Cytokine. 2018;111:342–349.
   PubMed Web of Science ®Google Scholar
• Pinto-Plata V, Toso J, Lee K, et al. Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax. 2007;62:595–601.
   PubMed Web of Science ®Google Scholar
• Chen H, Wang Y, Bai C, Wang X. Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation. J Proteomics. 2012;75:2835–2843.
   PubMed Web of Science ®Google Scholar
• Wagener AH, Yick CY, Brinkman P, van der Schee MP, Fens N, Sterk PJ. Toward composite molecular signatures in the phenotyping of asthma. Ann Am Thorac Soc. 2013;10(Suppl):S197–205.
   PubMedGoogle Scholar
• Gessner C, Scheibe R, Wötzel M, et al. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Med. 2005;99:1229–1240.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2009;41:631–638.
   PubMed Web of Science ®Google Scholar
• Fujimoto K, Yasuo M, Urushibata K, Hanaoka M, Koizumi T, Kubo K. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J. 2005;25:640–646.
   PubMed Web of Science ®Google Scholar
• Singanayagam A, Glanville N, Walton RP, et al. A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD. Clin Sci (Lond). 2015;129:245–258.
   PubMed Web of Science ®Google Scholar
• Edwards MR, Facchinetti F, Civelli M, Villetti G, Johnston SL. Anti-inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF6001 on virus-inducible cytokines. Pharmacol Res Perspect. 2016;4:e00202.
   PubMedGoogle Scholar
• Yao Y, Zhou J, Diao X, Wang S. Association between tumor necrosis factor-α and chronic obstructive pulmonary disease: a systematic review and meta-analysis. Ther Adv Respir Dis. 2019;13:1753466619866096.
   Web of Science ®Google Scholar
• Fenwick PS, Macedo P, Kilty IC, Barnes PJ, Donnelly LE. Effect of JAK inhibitors on release of CXCL9, CXCL10 and CXCL11 from human airway epithelial cells. PLoS One. 2015;10:e0128757.
   PubMed Web of Science ®Google Scholar
• Foronjy RF, Dabo AJ, Taggart CC, Weldon S, Geraghty P. Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice. PLoS One. 2014;9:e90567.
   PubMed Web of Science ®Google Scholar
• Egesten A, Eliasson M, Johansson HM, et al. The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis. 2007;195:684–693.
   PubMed Web of Science ®Google Scholar
• Waters JP, Pober JS, Bradley JR. Tumour necrosis factor in infectious disease. J Pathol. 2013;230:132–147.
   PubMed Web of Science ®Google Scholar
• Shebl FM, Pinto LA, García-Piñeres A, et al. Comparison of mRNA and protein measures of cytokines following vaccination with HPV-16 L1 virus like particles. Cancer Epidemiol Biomarkers Prev. 2010;19:978–981.
   PubMed Web of Science ®Google Scholar
• Chen G, Gharib TG, Huang CC, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics. 2002;1:304–313.
   PubMed Web of Science ®Google Scholar
• Zuo WL, Yang J, Strulovici-Barel Y, et al. Exaggerated BMP4 signalling alters human airway basal progenitor cell differentiation to cigarette smoking-related phenotypes. Eur Respir J. 2019;53:1702553.
   PubMed Web of Science ®Google Scholar
• Frey A, Lunding LP, Ehlers JC, Weckmann M, Zissler UM, Wegmann M. More than just a barrier: the immune functions of the airway epithelium in asthma pathogenesis. Front Immunol. 2020;11:761.
   PubMed Web of Science ®Google Scholar
• Zissler UM, Chaker AM, Effner R, et al. Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways. Mucosal Immunol. 2016;9:917–926.
   PubMed Web of Science ®Google Scholar
• Zissler UM, Ulrich M, Jakwerth CA, et al. Biomatrix for upper and lower airway biomarkers in patients with allergic asthma. J Allergy Clin Immunol. 2018;142:1980–1983.
   PubMed Web of Science ®Google Scholar